Sign in
CBLI Stock Price, Chart, Stats & News
Cytocom, Inc.
Save
226.39M
Market cap
–
Current P/E
–
Forward P/E
CBLI chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | 100.00% |
Operating margin | -983.70% |
Pretax margin | -855.62% |
Net margin | -912.16% |
Effective tax rate | -6.61% |
ROA | -103.47% |
ROE | -160.02% |
D/E | – |
Interest coverage ratio | – |
CBLI valuation
P/E | – |
P/S | 860.98x |
P/B | 19.52x |
P/CF | -16.56x |
P/FCF | -95.40x |
P/OCF | -16.56x |
PEG | -0.16x |
EV multiple | -95.66x |
About
Cleveland BioLabs, Inc. functions as a biopharmaceutical firm, specializing in the discovery and advancement of therapeutic drugs. Based in Buffalo, New York, the organization maintains a modest workforce of 15 full-time employees. Its primary objective involves pioneering methods to stimulate the body's immune defenses to tackle significant medical challenges.
Similar securities
Based on sector and market capitalization
Report issue